Form 4: Nutex Health CFO Jon Bates Settles Restricted Stock Units for Common Stock
SEC Form 4 Filing
Nutex Health's CFO, Jon Christian Bates, settled restricted stock units (RSUs) for shares of common stock on March 12, 2024.
Summary
- On March 12, 2024, Jon Christian Bates, the Chief Financial Officer of Nutex Health, Inc., settled 49,505 restricted stock units (RSUs).
- This settlement resulted in the acquisition of 49,505 shares of Nutex Health's common stock.
- Following the transaction, Mr. Bates directly owns 139,010 shares of common stock.
- The RSUs vested according to the Restricted Stock Unit Agreement dated April 1, 2023, with the reported transaction representing the second tranche of vesting.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine transaction related to executive compensation. The vesting of RSUs is a positive sign, but it's not a major event that would significantly impact the company's outlook.
Positives
- The vesting of RSUs and subsequent acquisition of common stock by a key executive could be seen as a sign of confidence in the company's future performance.
Future Outlook
The remaining RSUs will vest on March 1, 2025.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into the holdings of company insiders. This transaction is typical for executives receiving stock-based compensation.
Comparison to Industry Standards
- Executive compensation packages often include restricted stock units (RSUs) that vest over time, aligning executive interests with long-term shareholder value.
- The vesting schedule of the RSUs (three equal installments) is a common practice in executive compensation agreements.
- Similar companies in the healthcare sector, such as Universal Health Services or HCA Healthcare, also utilize RSUs as part of their executive compensation plans.
Stakeholder Impact
- Shareholders may view the increased ownership of common stock by the CFO as a positive sign, indicating confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| April 1, 2023 | Date of the Restricted Stock Unit Agreement between Nutex Health and Jon Bates. |
| March 1, 2024 | Date when the second tranche of RSUs vested. |
| March 1, 2025 | Date when the final tranche of RSUs will vest. |
| March 12, 2024 | Date of the transaction where RSUs were settled for common stock. |
| March 14, 2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.